Cargando…
Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554691/ https://www.ncbi.nlm.nih.gov/pubmed/36248330 http://dx.doi.org/10.21037/tlcr-22-492 |
| _version_ | 1784806757574377472 |
|---|---|
| author | De Giglio, Andrea Di Federico, Alessandro Metro, Giulio |
| author_facet | De Giglio, Andrea Di Federico, Alessandro Metro, Giulio |
| author_sort | De Giglio, Andrea |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9554691 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95546912022-10-13 Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer De Giglio, Andrea Di Federico, Alessandro Metro, Giulio Transl Lung Cancer Res Editorial AME Publishing Company 2022-09 /pmc/articles/PMC9554691/ /pubmed/36248330 http://dx.doi.org/10.21037/tlcr-22-492 Text en 2022 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial De Giglio, Andrea Di Federico, Alessandro Metro, Giulio Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer |
| title | Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer |
| title_full | Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer |
| title_fullStr | Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer |
| title_full_unstemmed | Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer |
| title_short | Exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with EGFR- or ALK-positive advanced non-small cell lung cancer |
| title_sort | exploring immune checkpoint inhibition in combination with anti-angiogenic therapy for patients with egfr- or alk-positive advanced non-small cell lung cancer |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554691/ https://www.ncbi.nlm.nih.gov/pubmed/36248330 http://dx.doi.org/10.21037/tlcr-22-492 |
| work_keys_str_mv | AT degiglioandrea exploringimmunecheckpointinhibitionincombinationwithantiangiogenictherapyforpatientswithegfroralkpositiveadvancednonsmallcelllungcancer AT difedericoalessandro exploringimmunecheckpointinhibitionincombinationwithantiangiogenictherapyforpatientswithegfroralkpositiveadvancednonsmallcelllungcancer AT metrogiulio exploringimmunecheckpointinhibitionincombinationwithantiangiogenictherapyforpatientswithegfroralkpositiveadvancednonsmallcelllungcancer |